Penny stock under Rs 10: This animal feed company bags a new order worth Rs 4,95,00,000 from one of Asia’s largest and India’s Top 10 Dairy suppliers

Kiran Shroff
/ Categories: Trending, Penny Stocks
Penny stock under Rs 10: This animal feed company bags a new order worth Rs 4,95,00,000 from one of Asia’s largest and India’s Top 10 Dairy suppliers

The stock is up by 88 per cent from its 52-week low of Rs 3.38 per share.

Ajooni Biotech Limited (NSE: AJOONI), Ajooni Biotech Limited is a PURE VEG. animal health care solutions company. It stands as a trailblazer, innovator, and frontrunner in the realm of animal feed production, prioritizing excellence in quality, safety, and production innovation, along with a commitment to delivering exceptional customer service. Ajooni bagged a significant prestigious order valued at Rs 4,95,00,000 from one of the largest dairy suppliers in Asia and among the top 10 in India. This milestone reflects the growing confidence in Ajooni Biotech's products and its commitment to expanding its market presence. In the organized listed space, Ajooni Biotech is the 1st PURE VEG. Cattle Feed & PURE VEG. feed Supplement Producer in the Industry.

The prestigious order will be executed within three months, after which the company will actively pursue additional opportunities. The dairy supplier has shown keen interest in Ajooni Biotech's PURE VEG. Cattle feed and PURE VEG. Supplements, underscoring the quality and effectiveness of its offerings.

In addition to this promising domestic development, Ajooni Biotech Limited has successfully initiated exports to TWO countries and is actively seeking further international opportunities. The company is dedicated to maintaining this momentum and fostering strong, long-term relationships with its clients. Ajooni Biotech remains optimistic about its growth trajectory and is committed to delivering consistent, high-quality products to its expanding customer base.

With the PURE VEG cattle feed and supplement feed operations running on autopilot, Ajooni Biotech Limited is now focusing on Moringa. Successful research and commercial production are set to commence in FY 2025-26. Moringa oil, extracted from the seeds, is a viable feedstock for biodiesel and aviation fuel. Additionally, the bark of the Moringa tree can be utilized to produce activated carbon.

  • In FY 2023- 24, the company reported revenue of Rs 82.30 crore, EBITDA of Rs 4.43 crore and Net Profit of Rs 2.17 crore.
  • In FY 2024-25, the company is expecting a total turnover of Rs 100 – Rs 140 crore.
  • In FY 2025-26, the company is expecting a total turnover of Rs 350 – Rs 410 crore.
  • In FY 2026-27, the company is expecting a total turnover of Rs 450 – Rs 495 crore with significant PAT.

Also Read: 1:1 Bonus Share: LIC-backed multibagger penny stock at Rs 4.07; Board allots 15,36,24,538 fully paid-up rights equity shares

About the Company

Ajooni Biotech Limited, a leading innovator in pure vegetarian animal healthcare solutions, prioritizes quality, safety, and production advancements to deliver exceptional service and a comprehensive feed range for both pure vegetarian animal feed and supplements. By partnering with Ajooni, you gain an experienced and knowledgeable ally with a deep understanding of the livestock market. Their focus is on optimizing productivity, meeting animals' complete nutritional needs through a pure vegetarian diet and achieving optimal dietary balance.

On Tuesday, shares of the company were locked in a 10 per cent upper circuit to Rs 6.35 per share from its previous closing of Rs 5.78. The company has a market cap of over Rs 100 crore. The stock’s 52-week high is Rs 6.90 and its 52-week low is Rs 3.38. The stock is up by 88 per cent from its 52-week low of Rs 3.38 per share.

Disclaimer: The article is for informational purposes only and not investment advice. 

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.

Rate this article:
3.8
Comments are only visible to subscribers.

Equity Research

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR